Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             63 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of DNA vaccines for the rabies-related virus, Mokola Nel, L.H
2003
21 19-20 p. 2598-2606
9 p.
artikel
2 Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? Clarke, S.C.
2003
21 19-20 p. 2468-2473
6 p.
artikel
3 Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms Burns, Victoria E
2003
21 19-20 p. 2523-2534
12 p.
artikel
4 Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response Syed, Faisal M.
2003
21 19-20 p. 2383-2393
11 p.
artikel
5 A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant Halperin, Scott A
2003
21 19-20 p. 2461-2467
7 p.
artikel
6 A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV) Huang, Yan
2003
21 19-20 p. 2500-2505
6 p.
artikel
7 Biodefense Vaccines, Therapeutics and Diagnostics: Policy, Funding, Development, Testing, Production, and Distribution Conference, June 2–4, 2003, Washington, DC 2003
21 19-20 p. 2690-
1 p.
artikel
8 CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation Brandão, Joana G.
2003
21 19-20 p. 2268-2272
5 p.
artikel
9 Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming Wang, Xiuqing
2003
21 19-20 p. 2288-2297
10 p.
artikel
10 Comments on the paper “The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data” [P. Rivest, R. Allard, Vaccine 20 (2002) 2533–2536] De Wals, Philippe
2003
21 19-20 p. 2260-2261
2 p.
artikel
11 CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice Pihlgren, Maria
2003
21 19-20 p. 2492-2499
8 p.
artikel
12 Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned Capiau, Carine
2003
21 19-20 p. 2273-2287
15 p.
artikel
13 Editorial Board 2003
21 19-20 p. IFC-
1 p.
artikel
14 Effect of infant immunisation with meningococcus serogroup C–CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children McVernon, Jodie
2003
21 19-20 p. 2573-2579
7 p.
artikel
15 Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct Nicholas, B.L.
2003
21 19-20 p. 2441-2447
7 p.
artikel
16 Effect of Vitamin A supplementation on the immune response to measles vaccination Cherian, Thomas
2003
21 19-20 p. 2418-2420
3 p.
artikel
17 Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate Plotnicky, Hélène
2003
21 19-20 p. 2651-2660
10 p.
artikel
18 Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation Kotecha, Minal T.
2003
21 19-20 p. 2506-2515
10 p.
artikel
19 Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280] Edelman, Robert
2003
21 19-20 p. 2689-
1 p.
artikel
20 Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: identification of shared and vaccine-specific genes in spleen lymphocytes Regnström, Karin
2003
21 19-20 p. 2307-2317
11 p.
artikel
21 Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids Rollman, E.
2003
21 19-20 p. 2263-2267
5 p.
artikel
22 HAV infection in chronic liver disease: a rationale for vaccination Almasio, Piero L.
2003
21 19-20 p. 2238-2241
4 p.
artikel
23 Hepatitis A: post-exposure prophylaxis Taliani, Gloria
2003
21 19-20 p. 2234-2237
4 p.
artikel
24 Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants Yeh, Sylvia H
2003
21 19-20 p. 2627-2631
5 p.
artikel
25 Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite–threonine–asparagine-rich protein (STARP) López, Ramsés
2003
21 19-20 p. 2404-2411
8 p.
artikel
26 IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis de Oliveira Mendes, Carolina
2003
21 19-20 p. 2589-2597
9 p.
artikel
27 Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1 Martina, Byron E.E
2003
21 19-20 p. 2433-2440
8 p.
artikel
28 Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys Tanabayashi, Kiyoshi
2003
21 19-20 p. 2338-2345
8 p.
artikel
29 Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis Piedra, Pedro A.
2003
21 19-20 p. 2448-2460
13 p.
artikel
30 Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2 Mozdzanowska, Krystyna
2003
21 19-20 p. 2616-2626
11 p.
artikel
31 Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) Nguyen, Christophe L.
2003
21 19-20 p. 2318-2328
11 p.
artikel
32 Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity Fowler, Sarah
2003
21 19-20 p. 2329-2337
9 p.
artikel
33 Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity Shanley, John D.
2003
21 19-20 p. 2632-2642
11 p.
artikel
34 Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6 de Lorimier, Arthur J
2003
21 19-20 p. 2548-2555
8 p.
artikel
35 Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine Halperin, Scott A.
2003
21 19-20 p. 2298-2306
9 p.
artikel
36 Novel configurations of high molecular weight species of the pertussis toxin vaccine component Fowler, Sarah
2003
21 19-20 p. 2678-2688
11 p.
artikel
37 Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine De Serres, Gaston
2003
21 19-20 p. 2346-2353
8 p.
artikel
38 OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei Meraldi, Valentin
2003
21 19-20 p. 2485-2491
7 p.
artikel
39 Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex Shkreta, Lulzim
2003
21 19-20 p. 2372-2382
11 p.
artikel
40 Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice Scappaticci, F.A.
2003
21 19-20 p. 2667-2677
11 p.
artikel
41 Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine Purcell, Robert H
2003
21 19-20 p. 2607-2615
9 p.
artikel
42 Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Ramiro, Maria J.
2003
21 19-20 p. 2474-2484
11 p.
artikel
43 Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach Senna, José P.M
2003
21 19-20 p. 2661-2666
6 p.
artikel
44 Reconstruction of measles dynamics in a vaccinated population Wallinga, J.
2003
21 19-20 p. 2643-2650
8 p.
artikel
45 Reply to the letter of Drs De Wals and De Serres Allard, Robert
2003
21 19-20 p. 2262-
1 p.
artikel
46 Risk groups for hepatitis A virus infection Franco, Elisabetta
2003
21 19-20 p. 2224-2233
10 p.
artikel
47 Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia Ito, Reiko
2003
21 19-20 p. 2362-2371
10 p.
artikel
48 Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age Qadri, Firdausi
2003
21 19-20 p. 2394-2403
10 p.
artikel
49 Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs Verheije, M.H.
2003
21 19-20 p. 2556-2563
8 p.
artikel
50 Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium) Van der Wielen, Marie
2003
21 19-20 p. 2412-2417
6 p.
artikel
51 Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS Fincham, John E.
2003
21 19-20 p. 2258-2259
2 p.
artikel
52 The association between psychosocial factors and vaccine-induced cytokine production Hayney, Mary S.
2003
21 19-20 p. 2428-2432
5 p.
artikel
53 The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination De Serres, Gaston
2003
21 19-20 p. 2354-2361
8 p.
artikel
54 The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine McIntosh, E.David G.
2003
21 19-20 p. 2564-2572
9 p.
artikel
55 The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity Wu, Suh-Chin
2003
21 19-20 p. 2516-2522
7 p.
artikel
56 The effectiveness and safety of hepatitis A vaccine: a systematic review Demicheli, Vittorio
2003
21 19-20 p. 2242-2245
4 p.
artikel
57 The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children Rager-Zisman, Bracha
2003
21 19-20 p. 2580-2588
9 p.
artikel
58 The incidence of shingles and its implications for vaccination policy Chapman, Rachel S.
2003
21 19-20 p. 2541-2547
7 p.
artikel
59 The role of vaccine in controlling hepatitis A epidemics D’Argenio, P
2003
21 19-20 p. 2246-2249
4 p.
artikel
60 The use of hepatitis a vaccination in Italy: an economic evaluation Demicheli, Vittorio
2003
21 19-20 p. 2250-2257
8 p.
artikel
61 The use of hepatitis A vaccine in Italy—evidence-based recommendations from an expert panel Mele, Alfonso
2003
21 19-20 p. 2223-
1 p.
artikel
62 Three types of immunotherapics against pythiosis insidiosi developed and evaluated Santurio, J.M
2003
21 19-20 p. 2535-2540
6 p.
artikel
63 Why do older people not get immunised against influenza? Evans, Meirion R.
2003
21 19-20 p. 2421-2427
7 p.
artikel
                             63 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland